Physician profile
Nabil S Gerges
NPI 1215199609
$16,669.91
in general payments reported to CMS, 2019-2025
52 companies · $4,254 in 2025
The $4,254 reported for 2025 was more than what 92% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,842 · 2020: $1,650 · 2021: $2,460 · 2022: $1,888 · 2023: $1,650 · 2024: $1,926 · 2025: $4,254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,748 · Travel and Lodging: $2,037 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,747.69 |
| Travel and Lodging | $2,036.80 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,536.22 | 2019-2025 | Proclaim, Eterna, Durata |
| Collegium Pharmaceutical, INC. | $1,601.36 | 2019-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,538.54 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $1,065.50 | 2019-2025 | Ztlido |
| Pfizer INC. | $949.24 | 2019-2025 | |
| Abbvie INC. | $855.50 | 2019-2025 | |
| Boston Scientific Corporation | $581.53 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $512.77 | 2019-2024 | Senza |
| Eisai INC. | $507.81 | 2020-2022 | |
| Supernus Pharmaceuticals, INC. | $439.03 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $434.68 | 2020-2021 | |
| Protega Pharmaceutials INC | $403.76 | 2022-2024 | Roxybond |
| Biodelivery Sciences International, INC. | $390.82 | 2019-2021 | |
| Horizon Therapeutics Plc | $375.88 | 2019-2022 | |
| Globus Medical, INC. | $366.23 | 2025 | Senza |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nabil Gerges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.